FVIII brings together FIXa and FX, allowing FXa and, ultimately, thrombin generation to proceed. The ACE910 bispecific antibody (against FIXa and FX) achieves the same action in the absence of FVIII. Professional illustration by Patrick Lane, ScEYEnce Studios.